Publication | Closed Access

Pegfilgrastim Appears Equivalent to Daily Dosing of Filgrastim to Treat Neutropenia After Autologous Peripheral Blood Stem Cell Transplantation in Patients With Non-Hodgkin Lymphoma

Lymphoid NeoplasiaCell TherapyTransplantationPegfilgrastim Appears EquivalentStem Cell TransplantationHematologyNon-hodgkin LymphomaBlood TransplantationDaily DosingRadiation OncologyMedicineCell TransplantationHealth Sciences